Literature DB >> 12021242

Leptin: a novel therapeutic role in lipodystrophy.

D B Savage1, S O'Rahilly.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12021242      PMCID： PMC150984          DOI： 10.1172/JCI15326

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  19 in total

1.  Effects of recombinant leptin therapy in a child with congenital leptin deficiency.

Authors:  I S Farooqi; S A Jebb; G Langmack; E Lawrence; C H Cheetham; A M Prentice; I A Hughes; M A McCamish; S O'Rahilly
Journal:  N Engl J Med       Date:  1999-09-16       Impact factor: 91.245

2.  Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice.

Authors:  O Gavrilova; B Marcus-Samuels; D Graham; J K Kim; G I Shulman; A L Castle; C Vinson; M Eckhaus; M L Reitman
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

3.  Editorial: leptin as a therapeutic agent--trials and tribulations.

Authors:  C S Mantzoros; J S Flier
Journal:  J Clin Endocrinol Metab       Date:  2000-11       Impact factor: 5.958

Review 4.  Obesity and insulin resistance.

Authors:  B B Kahn; J S Flier
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

5.  Role of leptin in the neuroendocrine response to fasting.

Authors:  R S Ahima; D Prabakaran; C Mantzoros; D Qu; B Lowell; E Maratos-Flier; J S Flier
Journal:  Nature       Date:  1996-07-18       Impact factor: 49.962

6.  Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes.

Authors:  E Arioglu; J Duncan-Morin; N Sebring; K I Rother; N Gottlieb; J Lieberman; D Herion; D E Kleiner; J Reynolds; A Premkumar; A E Sumner; J Hoofnagle; M L Reitman; S I Taylor
Journal:  Ann Intern Med       Date:  2000-08-15       Impact factor: 25.391

7.  Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones.

Authors:  L Chao; B Marcus-Samuels; M M Mason; J Moitra; C Vinson; E Arioglu; O Gavrilova; M L Reitman
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

8.  Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.

Authors:  I Shimomura; R E Hammer; S Ikemoto; M S Brown; J L Goldstein
Journal:  Nature       Date:  1999-09-02       Impact factor: 49.962

9.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans.

Authors:  R V Considine; M K Sinha; M L Heiman; A Kriauciunas; T W Stephens; M R Nyce; J P Ohannesian; C C Marco; L J McKee; T L Bauer
Journal:  N Engl J Med       Date:  1996-02-01       Impact factor: 91.245

10.  Efficacy of exogenous recombinant murine leptin in lean and obese 10- to 12-mo-old female CD-1 mice.

Authors:  M A Pelleymounter; M J Cullen; D Healy; R Hecht; D Winters; M McCaleb
Journal:  Am J Physiol       Date:  1998-10
View more
  7 in total

Review 1.  [Adipose tissue--an endocrine organ].

Authors:  M Blüher
Journal:  Internist (Berl)       Date:  2014-06       Impact factor: 0.743

Review 2.  Adipose tissue in control of metabolism.

Authors:  Liping Luo; Meilian Liu
Journal:  J Endocrinol       Date:  2016-12       Impact factor: 4.286

Review 3.  The role of leptin in glucose homeostasis.

Authors:  Heather C Denroche; Frank K Huynh; Timothy J Kieffer
Journal:  J Diabetes Investig       Date:  2012-03-28       Impact factor: 4.232

4.  Clinical relevance of adipokines.

Authors:  Matthias Blüher
Journal:  Diabetes Metab J       Date:  2012-10-18       Impact factor: 5.376

Review 5.  Adipokines - removing road blocks to obesity and diabetes therapy.

Authors:  Matthias Blüher
Journal:  Mol Metab       Date:  2014-01-21       Impact factor: 7.422

Review 6.  Drug development strategies for the treatment of obesity: how to ensure efficacy, safety, and sustainable weight loss.

Authors:  S Barja-Fernandez; R Leis; F F Casanueva; L M Seoane
Journal:  Drug Des Devel Ther       Date:  2014-12-01       Impact factor: 4.162

Review 7.  Adipokines as drug targets in diabetes and underlying disturbances.

Authors:  Vinícius Andrade-Oliveira; Niels O S Câmara; Pedro M Moraes-Vieira
Journal:  J Diabetes Res       Date:  2015-04-08       Impact factor: 4.011
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.